Related Experiment Videos
[Diabetic retinopathy and pregnancy]
1Clinique Ophtalmologique, Université libre de Bruxelles, Hôpitaux Brugmann et Saint-Pierre.
Bulletin De La Societe Belge D'Ophtalmologie
|January 1, 1995
Summary
Pregnancy significantly increases the risk of diabetic retinopathy, especially with longer diabetes duration and poor metabolic control. Regular retinal screenings are crucial for pregnant individuals with diabetes to monitor and manage eye health effectively.
Area of Science:
- Ophthalmology
- Endocrinology
- Reproductive Medicine
Context:
- Pregnancy is a critical period for women with diabetes, presenting unique challenges for managing chronic conditions.
- Diabetic retinopathy (DR) poses a significant risk to vision during pregnancy, influenced by several patient-specific factors.
- Existing research highlights the need for vigilant monitoring and timely intervention for DR in pregnant diabetic patients.
Purpose:
- To outline the risk factors associated with diabetic retinopathy progression during pregnancy.
- To establish recommended screening protocols for retinal examinations in pregnant individuals with diabetes.
- To inform clinical practice regarding the efficacy of laser treatment for diabetic retinopathy in pregnant patients.
Summary:
- Pregnancy is an independent risk factor for diabetic retinopathy (DR).
- Increased risk is associated with diabetes duration, metabolic control, hypertension, renal disease, anemia, rapid HbA1c reduction, and baseline DR severity.
- Recommended screening includes examination at pregnancy onset, every 3 months until 3 months postpartum, and monthly if retinopathy develops in high-risk patients.
- Laser treatment for DR is effective during pregnancy.
Impact:
- Highlights the importance of proactive ophthalmic surveillance in pregnant women with diabetes.
- Provides evidence-based guidelines for managing diabetic retinopathy during pregnancy.
- Aims to prevent vision loss and improve maternal and fetal outcomes by optimizing DR management.